Harvard Bioscience, Inc. (HBIO)
5.78
+0.10
(+1.76%)
USD |
NASDAQ |
May 27, 16:00
5.885
+0.10
(+1.82%)
After-Hours: 20:00
Harvard Bioscience EPS Diluted (Quarterly) : -0.7655 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 1.074 |
| Bio-Rad Laboratories, Inc. | -19.55 |
| Bruker Corp. | 0.0229 |
| Azenta, Inc. | -3.491 |
| Revvity, Inc. | 0.364 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.424M |
| Revenue (Quarterly) | 20.76M |
| Total Expenses (Quarterly) | 24.18M |
| Enterprise Value | 62.87M |
| Gross Profit Margin (Quarterly) | 55.04% |
| Profit Margin (Quarterly) | -16.50% |
| Earnings Yield | -37.98% |
| Operating Earnings Yield | 2.38% |
| Normalized Earnings Yield | -36.08 |